Clinical Research Directory
Browse clinical research sites, groups, and studies.
Universal Genetic Testing for Cancer Risk Reduction
Sponsor: NYU Langone Health
Summary
The purpose of this research study is to see if offering genetic testing for cancer-related genes is feasible and acceptable for patients presenting for gynecology clinic visits, instead of needing to see specialized providers or needing to meet specific criteria. The primary aim to assess the proportion of patients who undergo genetic testing, and the proportion of patients with pathogenic variants.
Key Details
Gender
FEMALE
Age Range
25 Years - 39 Years
Study Type
INTERVENTIONAL
Enrollment
600
Start Date
2025-03-04
Completion Date
2027-12-31
Last Updated
2026-03-02
Healthy Volunteers
Yes
Conditions
Interventions
Natera® Empower™ hereditary cancer panel test
The test will be the Natera® Empower™ hereditary cancer panel test and will be collected by saliva.
Specialist Referral
Participants with actionable pathogenic variants will be referred to the appropriate specialists (e.g., medical oncologist, gynecologic oncologist, breast surgeon) to discuss risk-reduction strategies and offered genetic counseling
Locations (1)
NYU Langone Health
New York, New York, United States